Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1934-1940

  Carter, J J ^a   Madeleine, M M ^a   Shera, K ^a   Schwartz, S M ^a   Cushing Haugen, K L ^a   Wipf, G C ^a   Porter, P ^a   Daling, J R ^a   McDougall, J K ^a   Galloway, D A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY RESPONSE; ANUS CANCER; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; FEMALE; GENITAL TRACT CANCER; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PAPILLOMA VIRUS; PRIORITY JOURNAL; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; VIRUS PARTICLE;

ADENOCARCINOMA; ADULT; ANTIBODIES, VIRAL; ANUS NEOPLASMS; CAPSID; CAPSID PROTEINS; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; TUMOR VIRUS INFECTIONS;

EID: 0035266160     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Natural history of cervicovaginal papillomavirus infection in young women
2. Humoral immune response to human papillomavirus infection
3. The serological response to papillomaviruses
4. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix
5. Comparison of HPV 16, 18 and 6 capsid antibody responses following incident infection
6. Stability over time of serum antibody levels to human papillomavirus type 16
7. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex type 2 infection
8. Cofactors with human papillomavirus in a population-based study of vulvar cancer
9. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer
10. A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix
11. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma
12. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study
13. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers
14. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers
15. Serum antibodies to HPV 16 virus-like particles are not associated with penile cancer in Chinese males
16. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
17. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia
18. The Surveillance, Epidemiology, and End Results Program: A national resource
19. Random digit dialing in selecting a population-based control group
20. Sampling methods for random digit dialing
21. Two one-step methods for household screening and interviewing using random digit dialing
22. Human papillomavirus infection in women with multicentric squamous cell neoplasia
23. Telomerase activation in cervical cancer
24. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers
25. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis
26. Serologic response to human papillomavirus type 16 (hpv-16) virus-like particles in hpv-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain
27. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix
28. Cigarette smoking and the risk of anogenital cancer
29. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
30. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection, and acquired immunodeficiency syndrome
31. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women
32. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia
33. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type-16
34. Sexually transmitted infection as a cause of anal cancer
35. p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva
36. Carcinoma of the vulva: HPV and p53 mutations
37. Human papillomaviru-specific serologic response in vulvar neoplasia
38. Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: A study of 41 cases using PCR
39. Detection of human papillomavirus in squamous neoplasm of the penis
40. Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction